Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1683596

registered interest
date	19/01/2024
answering body	Department for Business and Trade
answering dept id	214
answering dept short name	Business and Trade
answering dept sort name	Business and Trade
hansard heading	Oil: Russia
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business and Trade, if she will make an estimate of how much oil from Russia which has been refined in India has been imported as jet fuel since February 2022.
tabling member constituency	Brighton, Kemptown
tabling member printed	Lloyd Russell-Moyle
uin	10646
answer	answer is ministerial correction date of answer 24/01/2024 answer text <p>In line with WTO rules of origin, Russian oil which has been substantially processed (refined) in a third country is no longer considered to be of Russian origin.</p> answering member constituency Wealden answering member printed Ms Nusrat Ghani question first answered 24/01/2024 15:31:59 answering member 4460 label Biography information for Ms Nusrat Ghani
tabling member	4615 label Biography information for Lloyd Russell-Moyle

1683597

registered interest
date	19/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Anaesthesia Associates and Physician Associates
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she is taking steps to increase public awareness of the (a) roles and (b) competencies of (i) anaesthesia and (ii) physician associates in the NHS.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	10624
answer	answer is ministerial correction date of answer 26/01/2024 answer text <p>Anaesthesia associates (AAs) and physician associates (PAs) are integral parts of the multi-disciplinary healthcare team. The Government greatly values the work of AAs and PAs and is introducing regulation as part of our commitment to the roles, and to their place in the multi-disciplinary workforce.</p><p>The NHS Long Term Workforce Plan sets out significant expansion of the roles over the coming years, as part of plans to grow the multi-disciplinary workforce. The Government and NHS England are undertaking extensive engagement around this expansion to increase public and patient understanding of the roles and how they contribute to safe, effective patient care.</p><p>In primary care, NHS England has produced patient-facing materials that have been shared widely with general practices to support patient awareness and understanding of the PA role.</p><p>The National Institute for Health and Care Excellence guidelines set out that all healthcare professionals directly involved in a patient's care should introduce themselves and explain to the patient the roles and responsibilities of the different members of the healthcare team.</p><p>In advance of their regulation by the General Medical Council (GMC) later this year, the GMC has published interim standards for AAs and PAs which make it clear that professionals should always introduce their role to patients and set out their responsibilities in the team.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 26/01/2024 15:33:52 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4471 label Biography information for Rachael Maskell

1683598

registered interest
date	19/01/2024
answering body	Foreign, Commonwealth and Development Office
answering dept id	208
answering dept short name	Foreign, Commonwealth and Development Office
answering dept sort name	Foreign, Commonwealth and Development Office
hansard heading	Unitaid: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Minister of State, Foreign, Commonwealth and Development Office, whether he has had recent discussions with UNITAID on funding for that organisation.
tabling member constituency	Brighton, Kemptown
tabling member printed	Lloyd Russell-Moyle
uin	10647
answer	answer is ministerial correction date of answer 29/01/2024 answer text <p>The UK has been a strong supporter and partner of Unitaid for over 17 years. We highly value Unitaid's work to drive access to life-saving new health technologies for those who need them most.</p><p>The UK has a 20-year donor arrangement with Unitaid from 2007-2026 and has contributed £588 million to date. We continue to collaborate closely with Unitaid as a trusted partner. Allocations for 2025-26 and beyond will form part of the next Spending Review process, and the UK will work closely with multilateral partners through this process.</p> answering member constituency Sutton Coldfield answering member printed Mr Andrew Mitchell question first answered 29/01/2024 15:27:01 answering member 1211 label Biography information for Mr Andrew Mitchell
tabling member	4615 label Biography information for Lloyd Russell-Moyle

1683599

registered interest
date	19/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Haemolytic Uraemic Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the paper in Epidemiology and Infection 2023; 151: e160, entitled Haemolytic uraemic syndrome in children England, Wales, Northern Ireland, and Ireland: A prospective cohort study, published on 1 September 2023, if she will take steps to publish more accurate data on the number of cases of Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome identified by the UK Health Security Agency; and if her Department will take steps to increase funding for research into (a) cures and (b) treatments to improve long-term health outcomes for this illness.
tabling member constituency	Hayes and Harlington
tabling member printed	John McDonnell
uin	10583
answer	answer is ministerial correction date of answer 29/01/2024 answer text <p>Haemolytic Uraemic Syndrome (HUS) is a notifiable disease and cases are reported on a weekly basis by the UK Health Security Agency (UKHSA). The most common type of Shiga toxin-producing E.coli associated with HUS is also a notifiable pathogen, and the number of laboratory reported cases is published on a weekly basis by UKHSA. This data covers England and Wales, and is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/notifiable-diseases-causative-agents-reports-for-2024/noids-causative-agents-week-2-week-ending-14-january-2024" target="_blank">https://www.gov.uk/government/publications/notifiable-diseases-causative-agents-reports-for-2024/noids-causative-agents-week-2-week-ending-14-january-2024</a></p><p>The Department commissions research through the National Institute for Health and Care Research (NIHR). As the largest public funder for health and care research, the NIHR welcomes funding applications for research into any aspect of human health, including cures and treatments for HUS.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 29/01/2024 16:15:58 answering member 4492 label Biography information for Maria Caulfield
tabling member	178 label Biography information for John McDonnell

1683600

registered interest
date	19/01/2024
answering body	Cabinet Office
answering dept id	53
answering dept short name	Cabinet Office
answering dept sort name	Cabinet Office
hansard heading	Refugees: Afghanistan
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Minister for the Cabinet Office, with reference to the oral contribution of the Minister for Veterans’ Affairs during his oral statement on Afghan Resettlement Update of 13 December 2023, Official Report, column 911, whether the existing hotel contracts being extended apply only to new arrivals from Afghanistan.
tabling member constituency	Birmingham, Selly Oak
tabling member printed	Steve McCabe
uin	10588
answer	answer is ministerial correction date of answer 24/01/2024 answer text <p>The Government remains committed to ending the systemic use of hotels, and we do not plan to open new hotels to meet the increased demand from new arrivals from Afghanistan.</p><p>The information requested on hotel contracts is not publicly available; however, a small number of hotels with existing contracts have been extended for a limited time period to help accommodate Afghan Citizens Resettlement Scheme<strong> </strong>arrivals who have yet to be matched to settled housing solutions in the United Kingdom.</p><p> </p> answering member constituency Plymouth, Moor View answering member printed Johnny Mercer question first answered 24/01/2024 17:06:44 answering member 4485 label Biography information for Johnny Mercer
tabling member	298 label Biography information for Steve McCabe

1683601

registered interest
date	19/01/2024
answering body	Department for Education
answering dept id	60
answering dept short name	Education
answering dept sort name	Education
hansard heading	Overseas Students: Visas
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Education, what assessment she has made of the potential impact of changes to visas for international students and their dependents on the finances of universities.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	10625
answer	answer is ministerial correction date of answer 24/01/2024 answer text <p>The government has been successful in delivering the ambition in its International Education Strategy of hosting at least 600,000 students per year, by 2030, for two years running. The department expects that universities will adapt to reduced dependant numbers following the restrictions the government has introduced to control net migration.</p><p> </p><p>The department’s offer to international students remains very competitive and the department is committed to ensuring the UK remains a destination of choice for international students from across the globe. International students make a significant economic and cultural contribution to the UK’s higher education (HE) sector, which is good for our universities and delivers growth at home. Those affected by these changes will predominantly be dependants of international students. Students coming to the UK to undertake postgraduate research courses will not be affected by the new restriction on dependents.</p><p> </p><p>The Office for Students (OfS), as the regulator for HE in England, has responsibility for monitoring the financial sustainability of registered providers. The department works closely with the OfS to understand the ongoing impacts and changing landscape of financial sustainability in the sector.</p> answering member constituency Harlow answering member printed Robert Halfon question first answered 24/01/2024 17:14:50 answering member 3985 label Biography information for Robert Halfon
tabling member	4471 label Biography information for Rachael Maskell

1683602

registered interest
date	19/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Closures
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many community pharmacies have closed in each of the last 5 years.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	10626
answer	answer is ministerial correction date of answer 29/01/2024 answer text <p>The NHS Business Services Authority publishes official statistics which includes the number of pharmacies opening and closing in each financial year. The following table shows how many pharmacies opened or closed within the last five years:</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>Pharmacies opened</p></td><td><p>Pharmacies closed</p></td></tr><tr><td><p>2018/2019</p></td><td><p>220</p></td><td><p>347</p></td></tr><tr><td><p>2019/2020</p></td><td><p>239</p></td><td><p>405</p></td></tr><tr><td><p>2020/2021</p></td><td><p>236</p></td><td><p>451</p></td></tr><tr><td><p>2021/2022</p></td><td><p>308</p></td><td><p>418</p></td></tr><tr><td><p>2022/2023</p></td><td><p>297</p></td><td><p>388</p></td></tr></tbody></table><p> </p><p>Community pharmacies are private businesses that receive funding to provide pharmaceutical services for the National Health Service. The decision to close, divest or consolidate is a commercial decision made by the business owner. The Department is monitoring changes to the market closely. Access remains good, with 80% of people in England living within a 20 minutes’ walk from a local pharmacy, and with twice as many pharmacies in deprived areas.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom grouped question UIN 10631 9432 question first answered 29/01/2024 15:45:06 answering member 4117 label Biography information for Andrea Leadsom
tabling member	4471 label Biography information for Rachael Maskell

1683603

registered interest
date	19/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Artificial Intelligence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential merits of using artificial intelligence to undertake (a) assessments of medication for (i) compatibility and (ii) necessity and (b) other pharmaceutical checks.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	10627
answer	answer is ministerial correction date of answer 26/01/2024 answer text <p>The future of artificial intelligence (AI) technology and its potential benefits are exciting. We have already made great strides in this area and a number of projects are already underway, all with the aim of accelerating the safe, ethical, and effective use of AI in health and care. For example, we have invested £123 million to test and evaluate AI technologies in crucial areas that cause the most harm to health and the economy, such as strokes and lung cancer.</p><p>The Department has not yet made an assessment of the potential merits of using AI to undertake evaluations of the compatibility, necessity, and other pharmaceutical checks, for medication. However, we will continue to explore where AI could be deployed across health and care systems to transform patient experience and improve health outcomes.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 26/01/2024 15:44:42 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4471 label Biography information for Rachael Maskell

1683604

registered interest
date	19/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescription Drugs: Pharmacy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential merits of allowing pharmacists to prescribe alternative medications if those prescribed by a GP are not available without referring back to the GP.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	10628
answer	answer is ministerial correction date of answer 29/01/2024 answer text <p>Our assessment is that allowing pharmacists to take local action to alter prescriptions and supply an alternative without the full oversight of supply issues that the Department has, could have the effect of creating a knock-on shortage of the alternative and could thereby have the potential to exacerbate rather than mitigate supply problems. Furthermore, pharmacies will not know the reasons why a medicine has been prescribed, and in what particular way.</p><p>However, Serious Shortage Protocols (SSPs) enable community pharmacists to supply a specified medicine or device in accordance with a protocol rather than a prescription, with the patient’s consent, and without needing to seek authorisation from the prescriber. SSPs are an additional tool that have been used in recent years to manage and mitigate medicine and medical devices shortages. SSPs are not introduced unless sufficient supplies of the alternative product to be supplied in accordance with the SSP are available to support the market.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 29/01/2024 13:29:00 answering member 4117 label Biography information for Andrea Leadsom
tabling member	4471 label Biography information for Rachael Maskell

1683605

registered interest
date	19/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, for what reason there are medication shortages in the NHS; and if she will have discussions with the pharmaceutical industry on improving the supply.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	10629
answer	answer is ministerial correction date of answer 29/01/2024 answer text <p>There are approximately 14,000 licensed medicines and the overwhelming majority are in good supply. However, the medicine supply chain is highly regulated, complex, and global and supply disruption is a common issue which affects countries all around the world.</p><p>There are several reasons why supply can be disrupted, including manufacturing difficulties, regulatory non-compliance, access to raw materials, sudden demand spikes or distribution issues. Supply issues are driven by a range of factors, many of which are non-specific to the United Kingdom.</p><p>Whilst we cannot always prevent supply issues from occurring, the Department has a range of well-established processes and tools to manage them when they arise and help mitigate risks to patients. We work closely with industry, the National Health Service, and others to develop bespoke mitigation plans, which are tailored to each issue, to help ensure patients continue to have access to the medicines they need.</p><p>In some cases, an alternative supplier will be able to plug the gap with the exact same medicine. In others, patients will need to return to their clinician for review and consideration of the best treatment plan for them, for example switching to a different medicine. The team routinely shares up to date information about supply issues, for healthcare professionals, via an online Medicine Supply Tool, which is hosted by the Specialist Pharmacy Service.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 10630 question first answered 29/01/2024 16:58:22 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4471 label Biography information for Rachael Maskell